Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031
We often help patients transition away from GLP-1s by restoring their natural metabolic rhythm through nutrient optimization, hormone balancing, and digestive repair
This stable, water-soluble peptide resists degradation in the digestive tract, allowing for oral administration in addition to parenteral routes such as intramuscular or subcutaneous injection
Anti-inflammatory cytokine expression: The peptide shifts cytokine profiles toward anti-inflammatory patterns, reducing chronic inflammation that delays healing
US$ 22.09
US$ 21.91
US$ 28.46
US$ 27.79
US$ 20.29
US$ 20.25
US$ 28.29
US$ 29.49
US$ 23.09